SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals and Industries informs about newspaper publication

05 Nov 2025 Evaluate
Krebs Biochemicals and Industries has informed that it enclosed copies of the Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2025 approved in the Board Meeting held on November 4, 2025 and published on November 5, 2025 in Business Standard (English) and Prajasakti (Telugu).

The above information is a part of company’s filings submitted to BSE.  

Krebs Biochem.&Inds Share Price

60.00 -2.15 (-3.46%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×